Literature DB >> 17431878

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.

Nyla A Heerema1, Susana C Raimondi, James R Anderson, Jaclyn Biegel, Bruce M Camitta, Linda D Cooley, Paul S Gaynon, Betsy Hirsch, R Ellen Magenis, Loris McGavran, Shivanand Patil, Mark J Pettenati, Jeanette Pullen, Kathleen Rao, Diane Roulston, Nancy R Schneider, Jonathan J Shuster, Warren Sanger, Maxine J Sutcliffe, Peter van Tuinen, Michael S Watson, Andrew J Carroll.   

Abstract

Children with acute lymphoblastic leukemia (ALL) and high hyperdiploidy (>50 chromosomes) are considered to have a relatively good prognosis. The specific extra chromosomes are not random; extra copies of some chromosomes occur more frequently than those of others. We examined the extra chromosomes present in high hyperdiploid ALL to determine if there were a relation of the specific extra chromosomes and modal number (MN) and if the extra chromosomes present could differentiate high hyperdiploid from near-triploid and near-tetraploid cases. Karyotypes of 2,339 children with ALL and high hyperdiploidy at diagnosis showed a distinct nonrandom sequential pattern of gain for each chromosome as MN increased, with four groups of gain: chromosomes 21, X, 14, 6, 18, 4, 17, and 10 at MN 51-54; chromosomes 8, 5, 11, and 12 at MN 57-60; chromosomes 2, 3, 9,16, and 22 at MN 63-67; chromosomes 1, 7 13, 15, 19, and 20 at MN 68-79, and Y only at MN >or=80. Chromosomes gained at lower MN were retained as the MN increased. High hyperdiploid pediatric ALL results from a single abnormal mitotic division. Our results suggest that the abnormal mitosis involves specific chromosomes dependent on the number of chromosomes aberrantly distributed, raising provocative questions regarding the mitotic mechanism. The patterns of frequencies of tetrasomy of specific chromosomes differs from that of trisomies with the exception of chromosome 21, which is tetrasomic in a high frequency of cases at all MN. These results are consistent with different origins of high hyperdiploidy, near-trisomy, and near-tetrasomy.

Entities:  

Mesh:

Year:  2007        PMID: 17431878     DOI: 10.1002/gcc.20451

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  24 in total

1.  Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Erik Forestier; Henrik Lilljebjörn; Jesper Heldrup; Mikael Behrendtz; Bryan D Young; Bertil Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.

Authors:  Andrew J Carroll; Mary Shago; Fady M Mikhail; Susana C Raimondi; Betsy A Hirsch; Mignon L Loh; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Kelly W Maloney; Leonard A Mattano; Eric C Larsen; Julie Gastier-Foster; Eileen Stonerock; Denise Ell; Samir Kahwash; Meenakshi Devidas; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Stephen P Hunger; Naomi J Winick; William L Carroll; Kathleen W Rao; Nyla A Heerema
Journal:  Cancer Genet       Date:  2019-07-30

3.  Philadelphia-positive case negative for JAK2 V617F mutation with hyperdiploidic karyotype: A case report.

Authors:  Dragomira Nikolova; Vera Damyanova; Vasil Hrischev; Maria Markova; Lubomir Mitev; Aselina Asenova; Atanas Radinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2019-10-04

Review 4.  Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.

Authors:  Lindsay A Williams; Jun J Yang; Betsy A Hirsch; Erin L Marcotte; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-15       Impact factor: 4.254

5.  Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

Authors:  ZoAnn E Dreyer; Patricia A Dinndorf; Bruce Camitta; Harland Sather; Mei K La; Meenakshi Devidas; Joanne M Hilden; Nyla A Heerema; Jean E Sanders; Ron McGlennen; Cheryl L Willman; Andrew J Carroll; Fred Behm; Franklin O Smith; William G Woods; Kamar Godder; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

6.  Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.

Authors:  Stacey M Parker; Horatiu Olteanu; Peter VanTuinen; Colleen A Lawton; Christopher J Schultz; Kathleen K Christians; Timothy S Fenske
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

Review 7.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia.

Authors:  Krzysztof Mrózek; David P Harper; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

Review 8.  New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.

Authors:  Anthony V Moorman
Journal:  Haematologica       Date:  2016-04       Impact factor: 9.941

9.  Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia.

Authors:  Deborah French; Wenjian Yang; Cheng Cheng; Susana C Raimondi; Charles G Mullighan; James R Downing; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2008-12-09       Impact factor: 22.113

10.  High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.

Authors:  Kajsa Paulsson; Erik Forestier; Mette K Andersen; Kirsi Autio; Gisela Barbany; Georg Borgström; Lucia Cavelier; Irina Golovleva; Sverre Heim; Kristiina Heinonen; Randi Hovland; Johann H Johannsson; Eigil Kjeldsen; Ann Nordgren; Lars Palmqvist; Bertil Johansson
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.